Pamela Stephenson

Insider Reports History

Entity
Individual
Location
C/O Zynerba Pharmaceuticals, Inc., 80 W. Lancaster Avenue, Suite 300, Devon, PA
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pamela Stephenson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Disc Medicine, Inc. Chief Commercial Officer Common Stock 36.7K $2.48M $67.65 Feb 26, 2024 Direct
Disc Medicine, Inc. Chief Commercial Officer Stock Option (Right to Buy) 55K Feb 26, 2024 Direct
ALBIREO PHARMA, INC. Chief Commercial Officer Common Stock 0 $43.80 Mar 2, 2023 Direct
ALBIREO PHARMA, INC. Chief Commercial Officer Restricted Stock Units 0 Mar 2, 2023 Direct
ALBIREO PHARMA, INC. Chief Commercial Officer Stock Option (right to buy) 0 Mar 2, 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Common Stock 0 $1.33 Oct 10, 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 Oct 10, 2023 Direct

Insider Reports Filed by Pamela Stephenson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IRON Disc Medicine, Inc. Feb 26, 2024 2 $0 4 Feb 27, 2024 Chief Commercial Officer
IRON Disc Medicine, Inc. Feb 26, 2024 0 $0 3 Feb 27, 2024 Chief Commercial Officer
ZYNE Zynerba Pharmaceuticals, Inc. Oct 10, 2023 4 $0 4 Oct 11, 2023 Director
ZYNE Zynerba Pharmaceuticals, Inc. Jun 13, 2023 3 -$40 4 Jun 15, 2023 Director
ALBO ALBIREO PHARMA, INC. Mar 2, 2023 5 $0 4 Mar 2, 2023 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Jan 23, 2023 1 -$4.47K 4 Jan 23, 2023 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Jan 19, 2023 1 $0 4/A Jan 27, 2023 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Jan 19, 2023 1 -$77.9K 4 Jan 20, 2023 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Dec 27, 2022 1 -$8.94K 4/A Jan 9, 2023 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Oct 24, 2022 1 -$2.04K 4 Oct 25, 2022 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Sep 26, 2022 1 -$8.64K 4 Sep 27, 2022 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Jul 22, 2022 1 -$2.62K 4/A Jan 9, 2023 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Jun 27, 2022 1 -$8.98K 4 Jun 28, 2022 Chief Commercial Officer
ZYNE Zynerba Pharmaceuticals, Inc. Jun 14, 2022 3 -$40 4 Jun 16, 2022 Director
ALBO ALBIREO PHARMA, INC. Apr 22, 2022 1 -$3.39K 4 Apr 25, 2022 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Mar 28, 2022 1 -$13.9K 4 Mar 29, 2022 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Jan 24, 2022 1 -$10.4K 4 Jan 25, 2022 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Jan 18, 2022 1 $0 4 Jan 20, 2022 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Dec 27, 2021 1 -$11.3K 4 Dec 27, 2021 Chief Commercial Officer
ALBO ALBIREO PHARMA, INC. Sep 27, 2021 1 -$14.5K 4 Sep 28, 2021 Chief Commercial Officer
ZYNE Zynerba Pharmaceuticals, Inc. Aug 3, 2021 2 $0 4 Aug 5, 2021 Director
ALBO ALBIREO PHARMA, INC. Jun 25, 2021 1 -$17K 4 Jun 28, 2021 Chief Commercial Officer